Top Markets
#1 QuantixAI QuantixAI +63.44%
#2 UnifAI Network UnifAI Network +35.20%
#3 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +31.85%
#4 MowCat MowCat +31.24%
#5 GEKKO GEKKO +28.86%
#6 Prom Prom +27.97%
#7 MarsCoin MarsCoin +25.64%
#8 Kinesis Silver Kinesis Silver +24.26%
#9 Pons Pons +17.81%
#10 SuperVerse SuperVerse +17.76%
Coin of the day
QuantixAI QuantixAI
設定
言語
日本
通貨
USD
テーマ
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
株式のランク #20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
株価
$1.91
時価総額
$136.47M
変化（1日）
-1.15%
変化（1年）
21.17%
国
TW
取引 Sinew Pharma Inc. (6634)

カテゴリー

Healthcare
Sinew Pharma Inc.（6634）の利益
2026 時点の利益 TTM: 0
Sinew Pharma Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Sinew Pharma Inc. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US